Jeremy R. Graff files SEC Form 4 disclosures for Allarity Therapeutics, Inc.. They have made 1 open-market trade across 1 company since 2023, most recently 2026-09-30.
CIK 0001975028
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $2K since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| INAB | BUY | 2023-09-13 | 2023-09-15 | $0.95 | $2K | +17.4% | -2.3% | +154.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.